By Phil Boeyen, ShareChat Business News Editor
Thursday 7th September 2000
|Text too small?|
The two companies have agreed to form a long-term research and development partnership, which they say will combine Genesis's strengths in genomic discovery with Wrightson's agricultural marketing know-how.
One of the first areas to be looked at will be genomic research into pasture grasses.
The companies say independent research has already shown there is significant potential to increase productivity through better pasture quality and management, with sheep and cattle capable of gaining up to 30-40% in live weight.
Building on this type of work, Genesis and Wrightson says they will identify the genomic characteristics of grasses with desirable traits and work together to commercialise any new high animal productivity forage grasses.
"The work we plan to undertake aims to identify desirable gene traits that can be accelerated through natural breeding. There is no current plan for work on genetic modification. If a decision were taken later to engage in work in that area, it would be in accordance with the outcomes of the Royal Commission on Genetic Modification," says Genesis CEO Dr Jim Watson.
Wrightson CEO, Allan Freeth, says the partnership has enormous potential because it involves co-operation between agricultural, farming and business expertise, with a leading science and technology base.
"We see biotechnology as key to the future of New Zealand agriculture. Our partnership with Genesis, along with other strategic alliances and partnerships we will develop, will make a major contribution to our ability to deliver innovative and effective solutions for our customers."
Both companies expect the alliance will be a precursor to several other collaborations concerning key plants and animals in agriculture, and will jointly own the intellectual property developed through the partnership.
No comments yet
Genesis Research directors quit due to lack of funds & communication
Genesis Research has ‘lack of funds’, seeks legal advice on future
Genesis Research halted from trading pending statement
Genesis Research calls off proposed merger with Mariposa Health
Kupe earnings bolster Genesis 1H profit by 125%
Genesis Research plans "reverse takeover"
Genesis Research director Graham Chin resigns in wake of rift with UBNZ
Tekapo purchase knocks $73m off Genesis bottom line
UBNZ gets in deeper with Genesis Research
Genesis Energy beats forecast